Most clinicians recommend comprehensive blood work every 3 to 6 months during ongoing treatment
No, Combining two GLP-1 class compounds would not be appropriate in any clinical or research context and could cause significant adverse effects
If you experience any suspected side effects whilst taking Wegovy, you can report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
Int J Biochem Cell Biol 41(10):20152024 Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, Trojanowski JQ, Lee VM, Ischiropoulos H (2001) Induction of alpha-synuclein aggregation by intracellular nitrative insult
1 Commercially insured patients are expected to pay as little as $25 per month with the Wegovy savings offer according to Novo Nordisk